Zhidong Chen

957 total citations
18 papers, 731 citations indexed

About

Zhidong Chen is a scholar working on Molecular Biology, Biomaterials and Computational Theory and Mathematics. According to data from OpenAlex, Zhidong Chen has authored 18 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Biomaterials and 4 papers in Computational Theory and Mathematics. Recurrent topics in Zhidong Chen's work include Computational Drug Discovery Methods (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Acute Myeloid Leukemia Research (2 papers). Zhidong Chen is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Acute Myeloid Leukemia Research (2 papers). Zhidong Chen collaborates with scholars based in China, United States and Canada. Zhidong Chen's co-authors include Xiaowei Zeng, Lin Mei, Zimu Li, Xiaoshu Chen, Suhua Shi, Xionglei He, Wenfeng Zeng, Xiaoting Shan, Nansha Gao and Xunzhang Wang and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Zhidong Chen

17 papers receiving 721 citations

Peers

Countries citing papers authored by Zhidong Chen

Since Specialization

Citations

This map shows the geographic impact of Zhidong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhidong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhidong Chen more than expected).

Fields of papers citing papers by Zhidong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhidong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhidong Chen. The network helps show where Zhidong Chen may publish in the future.

Co-authorship network of co-authors of Zhidong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhidong Chen. A scholar is included among the top collaborators of Zhidong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhidong Chen. Zhidong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Modulating the complement system through epitope-specific inhibition by complement C3 inhibitors 2025 ·Journal of Biological Chemistry ·Zhidong Chen, (unknown), (unknown), Yi Xia, Huizhu Liu, Feng Qian	0
2	Targeted Penetrating Motif Engineering of BH3 Mimetic: Harnessing Non‐Canonical Amino Acids for Coinhibition of MCL‐1 and BCL‐xL in Acute Myeloid Leukemia 2025 ·Advanced Science ·Zhe Wang, (unknown), Xinpei Wang, Xu Chen, (unknown), Shengbin Li, Xiaohui Qiu, (unknown), (unknown), (unknown), Zhidong Chen, Junqing Wang	2
3	Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems 2023 ·Pharmaceutics ·(unknown), (unknown), (unknown), Yongxiao Li, (unknown), Xiaohui Qiu, Xu Chen, Zhidong Chen, Bobin Mi, Meiying Wu, Junqing Wang	32
4	A high-throughput molecular dynamics screening (HTMDS) approach to the design of novel cyclopeptide inhibitors of ATAD2B based on the non-canonical combinatorial library 2023 ·Journal of Biomolecular Structure and Dynamics ·Zhidong Chen, Yongxiao Li, Xinpei Wang, Xiaohui Qiu, Chenglin Wang, Zhe Wang, Xu Chen, Junqing Wang	4
5	Reconfigurable Peptide Analogs of Apolipoprotein A-I Reveal Tunable Features of Nanodisc Assembly 2023 ·Langmuir ·(unknown), Xu Chen, Yongxiao Li, Zhidong Chen, (unknown), Xinpei Wang, Yonghui Lv, (unknown), Meiying Wu, Gang Liu, Junqing Wang	7
6	An in Silico Approach to Reveal the Nanodisc Formulation of Doxorubicin 2022 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Xu Chen, Zhidong Chen, Yonghui Lv, Yongxiao Li, Shengbin Li, (unknown), (unknown), Xinpei Wang, Zirui Chen, (unknown), Tianqi Wang, (unknown), Meiying Wu, Junqing Wang	5
7	Polyphenol-based hydrogels: Pyramid evolution from crosslinked structures to biomedical applications and the reverse design 2022 ·Bioactive Materials ·Zimu Li, Zhidong Chen, Hongzhong Chen, Kebing Chen, Wei Tao, Xiao–kun Ouyang, Lin Mei, Xiaowei Zeng	131
8	Melittin Tryptophan Substitution with a Fluorescent Amino Acid Reveals the Structural Basis of Selective Antitumor Effect and Subcellular Localization in Tumor Cells 2022 ·Toxins ·Yonghui Lv, Xu Chen, Zhidong Chen, (unknown), Yongxiao Li, (unknown), (unknown), Xinpei Wang, (unknown), Shengbin Li, (unknown), Meiying Wu, Junqing Wang	14
9	Harnessing Protein Corona for Biomimetic Nanomedicine Design 2022 ·Biomimetics ·Zhidong Chen, Xu Chen, Juyang Huang, Junqing Wang, (unknown)	22
10	De novo Design of G Protein-Coupled Receptor 40 Peptide Agonists for Type 2 Diabetes Mellitus Based on Artificial Intelligence and Site-Directed Mutagenesis 2021 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Zhidong Chen, (unknown), (unknown), Yongxiao Li, Shengbin Li, Junqing Wang, Zhe Wang	10
11	A novel artificial intelligence protocol to investigate potential leads for diabetes mellitus 2021 ·Molecular Diversity ·(unknown), Lu Zhao, Guanxing Chen, Xu Chen, Zhidong Chen, Calvin Yu‐Chian Chen	11
12	A novel artificial intelligence protocol to investigate potential leads for Parkinson's disease 2020 ·RSC Advances ·Zhidong Chen, Lu Zhao, Hsin‐Yi Chen, (unknown), Xu Chen, Calvin Yu‐Chian Chen	15
13	Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration 2020 ·Advanced Science ·Zimu Li, Xiaoting Shan, Zhidong Chen, Nansha Gao, Wenfeng Zeng, Xiaowei Zeng, Lin Mei	190
14	A novel artificial intelligence protocol for finding potential inhibitors of acute myeloid leukemia 2020 ·Journal of Materials Chemistry B ·Xu Chen, Hsin‐Yi Chen, Zhidong Chen, (unknown), Calvin Yu‐Chian Chen	12
15	Nucleosomes Suppress Spontaneous Mutations Base-Specifically in Eukaryotes 2012 ·Science ·Xiaoshu Chen, Zhidong Chen, Han Chen, Zhijian Su, (unknown), Fangqin Lin, Suhua Shi, Xionglei He	69
16	He et al. reply 2011 ·Nature Genetics ·Xionglei He, Xiaoshu Chen, Yuanyan Xiong, Zhidong Chen, Xunzhang Wang, Suhua Shi, Xueqin Wang, Jianzhi Zhang	20
17	Genome-wide Gene Expression Profiling Reveals Aberrant MAPK and Wnt Signaling Pathways Associated with Early Parthenogenesis 2010 ·Journal of Molecular Cell Biology ·Na Liu, Steve Enkemann, Ping Liang, Remko Hersmus, (unknown), Junjiu Huang, Chao Wu, Zhidong Chen, Leendert H. J. Looijenga, David L. Keefe, Lulu Liu	36
18	RNA sequencing shows no dosage compensation of the active X-chromosome 2010 ·Nature Genetics ·Yuanyan Xiong, Xiaoshu Chen, Zhidong Chen, Xunzhang Wang, Suhua Shi, Xueqin Wang, Jianzhi Zhang, Xionglei He	151

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact